Schedule (route) |
Endpoint |
Vehicle |
Dose |
Treated/Control (%) |
Observations |
Q01DX001 (ip) |
mean survival time |
saline |
50.0 mg/kg/injection |
100.0 |
Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
Q01DX001 (ip) |
mean survival time |
saline |
100.0 mg/kg/injection |
89.0 |
Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
Q01DX001 (ip) |
mean survival time |
saline |
200.0 mg/kg/injection |
105.0 |
Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
Q04DX003 (ip) |
mean survival time |
saline |
100.0 mg/kg/injection |
107.0 |
Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
Q04DX003 (ip) |
mean survival time |
saline |
200.0 mg/kg/injection |
107.0 |
Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
Q04DX003 (ip) |
mean survival time |
saline |
400.0 mg/kg/injection |
110.0 |
Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |